University of Pennsylvania Department of Bioengineering
by Dave Meaney In the aftermath of the presidential election, quite a few experts cited the lack of economic opportunity for many as a primary factor that elevated Donald Trump to the presidency. These changes in economic opportunity did not occur months prior to the election, but they resulted from years of continual changes in …
Neil Sheppard, Adjunct Associate Professor of Pathology and Laboratory Medicine in the Perelman School of Medicine, and David Mai, a Bioengineering graduate student in the School of Engineering and Applied Science, explained the findings of their recent study, which offered a potential strategy to improve T cell therapy in solid tumors, to the European biotech …
Continue reading “Penn Bioengineering Graduate Student on T Cell Therapy Improvements”
A new Penn Medicine preclinical study demonstrates a simultaneous ‘knockout’ of two inflammatory regulators boosts T cell expansion to attack solid tumors. by Meagan Raeke A new approach that delivers a “one-two punch” to help T cells attack solid tumors is the focus of a preclinical study by researchers from the Perelman School of Medicine. …
Continue reading “A Potential Strategy to Improve T Cell Therapy in Solid Tumors”